Patients with higher levels of TNF-α and IL-10 at two weeks after HSCT develop moderate-to-severe GvHD in the post-transplant period in comparison to patients with relatively lower TNF-α and IL-10 levels which can be correlated with a lower GvHD grade [17]. The gene discussed is IL10; the disease is graft versus host disease.